TY  - JOUR
T1  - Maxillary Bone Necrosis Following the Use of Bisphosphonates in Patients with Cancer: Management and Case Series
AU - , Silvia Tortorici AU - , Francesco Burruano AU - , Luigi Caradonna AU - , Maria Lidia Buzzanca AU - , Paolo Difalco 
JO  - Research Journal of Biological Sciences
VL  - 3
IS  - 8
SP  - 925
EP  - 929
PY  - 2008
DA  - 2001/08/19
SN  - 1815-8846
DO  - rjbsci.2008.925.929
UR  - https://makhillpublications.co/view-article.php?doi=rjbsci.2008.925.929
KW  - Bisphosphonates
KW  -bone necrosis
KW  -avascular necrosis of the jaw
KW  -cancer
KW  -case series
AB  - Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.
ER  -